Quidel Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Quidel Corp (QDEL) Tops Q2 EPS by 12c, Slight Beat on Revenues
August 7, 2018 4:32 PM EDTQuidel Corp (NASDAQ: QDEL) reported Q2 EPS of $0.36, $0.12 better than the analyst estimate of $0.24. Revenue for the quarter came in at $103.2 million versus the consensus estimate of $103.11 million.
Total revenue was $103.2 million as compared to $38.3 million in the second quarter of 2017.Cardiac Immunoassay revenue was $69.9 million.Influenza revenue was $5.5 million as compared to $10.1 million in the second quarter of 2017.Reduced debt by an additional $98.6 million through convertible note exchange and accelerated Senior... More